Journal article
Use and safety of immunotherapeutic management of n-methyl-d-aspartate receptor antibody encephalitis: a meta-analysis
- Abstract:
-
Importance: Overall, immunotherapy has been shown to improve outcomes and reduce relapses in individuals with N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis (NMDARE); however, the superiority of specific treatments and combinations remains unclear.
Objective: To map the use and safety of immunotherapies in individuals with NMDARE, identify early predictors of poor functional outcome and relapse, evaluate changes in immunotherapy use an...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 611.4KB, Terms of use)
-
- Publisher copy:
- 10.1001/jamaneurol.2021.3188
Authors
+ Wellcome Trust
More from this funder
- Funder identifier:
- https://ror.org/029chgv08
- Grant:
- 104079/Z/14/Z
+ Medical Research Council
More from this funder
- Funder identifier:
- https://ror.org/03x94j517
- Grant:
- MR/V007173/1
- Publisher:
- American Medical Association
- Journal:
- JAMA Neurology More from this journal
- Volume:
- 78
- Issue:
- 11
- Pages:
- 1333-1344
- Place of publication:
- United States
- Publication date:
- 2021-11-11
- Acceptance date:
- 2021-07-30
- DOI:
- EISSN:
-
2168-6157
- ISSN:
-
2168-6149
- Pmid:
-
34542573
- Language:
-
English
- Keywords:
- Pubs id:
-
1195512
- Local pid:
-
pubs:1195512
- Deposit date:
-
2025-02-07
- ARK identifier:
Terms of use
- Copyright holder:
- Nosadini et al
- Copyright date:
- 2021
- Rights statement:
- © 2021 Nosadini M et al. This is an open access article distributed under the terms of the CC-BY License.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record